News from the MCRC
Early detection in hereditary cancers
We speak to Dr Emma Woodward about a Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
MB-PhD Summer Placements 2022
This year we are again offering University of Manchester MBChB and University of St Andrews…
MCRC-DCS Postgraduate Research Showcase 2022
Held on the 12th-13th May 2022, members of the organising committee reflect on the first…
Is Pursuing ‘a Passion for…
Study identifies best treatment for rare childhood cancer
Dr Martin McCabe presented the results of the rEECur study into recurrent and primary refractory…
#PrideInResearch at the MCRC –…
Professor Tim Illidge awarded a…
Professor Tim Illidge has been recognised for his contributions to radiotherapy and lymphoma research
MCRC Director’s Update – May 2022
Indoor tanning ban would reduce…
MCRC Director’s Update – April 2022
MCRC Director’s Update – March 2022
Visiting leadership in Kenya, five more years of funding for the Cancer Research UK Manchester…
On Cancer Westminster Launch
The ALETHEIA framework in radiation oncology
Dr Marianne Aznar explains the ALETHEIA Framework, an AI toolkit developed by Rolls-Royce, and how…
MCRC-DCS Alumni Showcase
Manchester Cancer Research Centre and Division of Cancer Sciences clinical and non-clinical PhD alumni discuss…
